226 related articles for article (PubMed ID: 20734172)
21. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in managing overactive bladder.
Araklitis G; Baines G; da Silva AS; Robinson D; Cardozo L
F1000Res; 2020; 9():. PubMed ID: 32968482
[TBL] [Abstract][Full Text] [Related]
23. Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.
De Wachter S; Benson KD; Dmochowski RR; Rovner ES; Versi E; Miller LE; Tu LM
J Urol; 2019 Mar; 201(3):573-580. PubMed ID: 30240691
[TBL] [Abstract][Full Text] [Related]
24. [Laparoscopic augmentation enterocystoplasty: initial experience].
Núñez Mora C; Cansino Alcaide R; Alonso Gregorio S; Martínez-Piñeiro LL; De la Peña Barthel J
Actas Urol Esp; 2007 Jan; 31(1):17-22. PubMed ID: 17410981
[TBL] [Abstract][Full Text] [Related]
25. Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.
Shreck E; Gioia K; Lucioni A
Curr Urol Rep; 2016 Apr; 17(4):27. PubMed ID: 26902621
[TBL] [Abstract][Full Text] [Related]
26. Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.
Nik-Ahd F; Lenore Ackerman A; Anger J
Curr Urol Rep; 2018 Sep; 19(11):94. PubMed ID: 30215140
[TBL] [Abstract][Full Text] [Related]
27. Management of overactive bladder syndrome.
Srikrishna S; Robinson D; Cardozo L; Vella M
Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
[TBL] [Abstract][Full Text] [Related]
28. Management of overactive bladder.
Gulur DM; Drake MJ
Nat Rev Urol; 2010 Oct; 7(10):572-82. PubMed ID: 20930868
[TBL] [Abstract][Full Text] [Related]
29. Surgical options for drug-refractory overactive bladder patients.
Starkman JS; Smith CP; Staskin DR
Rev Urol; 2010; 12(2-3):e97-e110. PubMed ID: 20811558
[TBL] [Abstract][Full Text] [Related]
30. Outcome of coexistent overactive bladder symptoms in women with urodynamic urinary incontinence following anti-incontinence surgery.
Liang CC; Hsieh WC; Huang L
Int Urogynecol J; 2017 Apr; 28(4):605-611. PubMed ID: 27678141
[TBL] [Abstract][Full Text] [Related]
31. Overactive bladder syndrome: Management and treatment options.
Hutchinson A; Nesbitt A; Joshi A; Clubb A; Perera M
Aust J Gen Pract; 2020 Sep; 49(9):593-598. PubMed ID: 32864677
[TBL] [Abstract][Full Text] [Related]
32. Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.
Haab F
Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S2-5. PubMed ID: 25042138
[TBL] [Abstract][Full Text] [Related]
33. One-year results with selective bladder denervation in women with refractory overactive bladder.
Rovner ES; Versi E; Le Mai T; Dmochowski RR; De Wachter S
Neurourol Urodyn; 2019 Nov; 38(8):2178-2184. PubMed ID: 31359508
[TBL] [Abstract][Full Text] [Related]
34. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
Yüce T; Dökmeci F; Çetinkaya ŞE
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
[TBL] [Abstract][Full Text] [Related]
35. The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: A randomized controlled trial.
Voorham JC; De Wachter S; Van den Bos TWL; Putter H; Lycklama À Nijeholt GA; Voorham-van der Zalm PJ
Neurourol Urodyn; 2017 Sep; 36(7):1796-1803. PubMed ID: 27869312
[TBL] [Abstract][Full Text] [Related]
36. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.
Watanabe JH; Campbell JD; Ravelo A; Chancellor MB; Kowalski J; Sullivan SD
Urology; 2010 Oct; 76(4):835-40. PubMed ID: 20430422
[TBL] [Abstract][Full Text] [Related]
37. Overactive bladder: diagnosis and management.
Robinson D; Cardozo L
Maturitas; 2012 Feb; 71(2):188-93. PubMed ID: 22197347
[TBL] [Abstract][Full Text] [Related]
38. Update on the management of overactive bladder.
Fontaine C; Papworth E; Pascoe J; Hashim H
Ther Adv Urol; 2021; 13():17562872211039034. PubMed ID: 34484427
[TBL] [Abstract][Full Text] [Related]
39. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
40. Intravesical electrical stimulation treatment for overactive bladder: An observational study.
Yune JJ; Shen JK; Pierce MA; Hardesty JS; Kim J; Siddighi S
Investig Clin Urol; 2018 Jul; 59(4):246-251. PubMed ID: 29984339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
